Luteinizing hormone receptor (lhcgr) as a marker gene for characterizing estrogenic endocrine-disrupting chemicals in zebrafish ovarian follicle cells

General and Comparative Endocrinology

Volumn 192, Issue , 2013, Pages 89-94

  Liu, Ka Cheuk ^a   Wu, Rudolf S S ^b   Ge, Wei ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

EDCs; Follicle cells; Lhcgr; Ovary; Zebrafish

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; 2,2',4,4' TETRABROMODIPHENYL ETHER; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTRADIOL; ETHER DERIVATIVE; ETHINYLESTRADIOL; GENISTEIN; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; UNCLASSIFIED DRUG; VINCLOZOLIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EF1A GENE; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HOUSEKEEPING GENE; IN VITRO STUDY; INHBAB GENE; INTRACELLULAR SIGNALING; LUTEINIZING HORMONE RECEPTOR GENE; MARKER GENE; NONHUMAN; OVARY CELL CULTURE; OVARY FOLLICLE CELL; PRIORITY JOURNAL; ZEBRA FISH;

EDCS; FOLLICLE CELLS; LHCGR; OVARY; ZEBRAFISH;

ANIMALS; ENDOCRINE DISRUPTORS; ESTROGENS; FEMALE; OVARIAN FOLLICLE; RECEPTORS, LH; ZEBRAFISH;

EID: 84884414396     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2013.06.023     Document Type: Article

References (36)

1. Brawand D., Wahli W., Kaessmann H. Loss of egg yolk genes in mammals and the origin of lactation and placentation. PLoS Biol. 2008, 6:e63.
2. Carnevali O., Tosti L., Speciale C., Peng C., Zhu Y., Maradonna F. DEHP impairs zebrafish reproduction by affecting critical factors in oogenesis. PLoS One 2010, 5:e10201.
3. Celander M.C. Cocktail effects on biomarker responses in fish. Aquat. Toxicol. 2011, 105:72-77.
4. Chung C.K., Ge W. Human chorionic gonadotropin (hCG) induces MAPK3/1 phosphorylation in the zebrafish ovarian follicle cells independent of EGF/EGFR pathway. Gen. Comp. Endocrinol. 2013, 188:251-257.
5. Cowin P.A., Gold E., Aleksova J., O'Bryan M.K., Foster P.M., Scott H.S., Risbridger G.P. Vinclozolin exposure in utero induces postpubertal prostatitis and reduces sperm production via a reversible hormone-regulated mechanism. Endocrinology 2010, 151:783-792.
6. Dang V.H., Choi K.C., Jeung E.B. Tetrabromodiphenyl ether (BDE 47) evokes estrogenicity and calbindin-D9k expression through an estrogen receptor-mediated pathway in the uterus of immature rats. Toxicol. Sci. 2007, 97:504-511.
7. DeVito M.J., Thomas T., Martin E., Umbreit T.H., Gallo M.A. Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD1 mice. Toxicol. Appl. Pharmacol. 1992, 113:284-292.
8. DiMuccio T., Mukai S.T., Clelland E., Kohli G., Cuartero M., Wu T., Peng C. Cloning of a second form of activin-βA cDNA and regulation of activin-βA subunits and activin type II receptor mRNA expression by gonadotropin in the zebrafish ovary. Gen. Comp. Endocrinol. 2005, 143:287-299.
9. Edmunds J.S., McCarthy R.A., Ramsdell J.S. Permanent and functional male-to-female sex reversal in d-rR strain medaka (Oryzias latipes) following egg microinjection of o,p'-DDT. Environ. Health Perspect. 2000, 108:219-224.
10. Fernandez M.F., Arrebola J.P., Taoufiki J., Navalon A., Ballesteros O., Pulgar R., Vilchez J.L., Olea N. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod. Toxicol. 2007, 24:259-264.
11. Fisher J.S. Are all EDC effects mediated via steroid hormone receptors?. Toxicology 2004, 205:33-41.
12. Folmar L.C., Hemmer M.J., Denslow N.D., Kroll K., Chen J., Cheek A., Richman H., Meredith H., Grau E.G. A comparison of the estrogenic potencies of estradiol, ethynylestradiol, diethylstilbestrol, nonylphenol and methoxychlor in vivo and in vitro. Aquat. Toxicol. 2002, 60:101-110.
13. Fowler P.A., Bellingham M., Sinclair K.D., Evans N.P., Pocar P., Fischer B., Schaedlich K., Schmidt J.S., Amezaga M.R., Bhattacharya S., Rhind S.M., O'Shaughnessy P.J. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol. Cell. Endocrinol. 2012, 355:231-239.
14. Harris C.A., Henttu P., Parker M.G., Sumpter J.P. The estrogenic activity of phthalate esters in vitro. Environ. Health Perspect. 1997, 105:802-811.
15. Hotchkiss A.K., Rider C.V., Blystone C.R., Wilson V.S., Hartig P.C., Ankley G.T., Foster P.M., Gray C.L., Gray L.E. Fifteen years after "Wingspread"-environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol. Sci. 2008, 105:235-259.
16. Hsieh C.Y., Santell R.C., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998, 58:3833-3838.
17. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Rolland R., Scott G., Sheehan D.M., Sinks T., Tilson H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the US. EPA-sponsored workshop. Environ. Health Perspect. 1996, 104(Suppl. 4):715-740.
18. Kwok H.F., So W.K., Wang Y., Ge W. Zebrafish gonadotropins and their receptors: I. Cloning and characterization of zebrafish follicle-stimulating hormone and luteinizing hormone receptors - evidence for their distinct functions in follicle development. Biol. Reprod. 2005, 72:1370-1381.
19. Legler J., Zeinstra L.M., Schuitemaker F., Lanser P.H., Bogerd J., Brouwer A., Vethaak A.D., De Voogt P., Murk A.J., Van der Burg B. Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environ. Sci. Technol. 2002, 36:4410-4415.
20. Liu K.C., Ge W. Evidence for gating roles of protein kinase A and protein kinase C in estradiol-induced luteinizing hormone receptor (lhcgr) expression in zebrafish ovarian follicle cells. PLoS One 2013, 8:e62524.
21. Liu K.C., Ge W. Differential regulation of gonadotropin receptors (fshr and lhcgr) by epidermal growth factor (EGF) in the zebrafish ovary. Gen. Comp. Endocrinol. 2013, 181:288-294.
22. Liu K.C., Lin S.W., Ge W. Differential regulation of gonadotropin receptors (fshr and lhcgr) by estradiol in the zebrafish ovary involves nuclear estrogen receptors that are likely located on the plasma membrane. Endocrinology 2011, 152:4418-4430.
23. Nakari T., Pessala P. In vitro estrogenicity of polybrominated flame retardants. Aquat. Toxicol. 2005, 74:272-279.
24. Navas J.M., Segner H. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances. Aquat. Toxicol. 2006, 80:1-22.
25. Nunez A.A., Kannan K., Giesy J.P., Fang J., Clemens L.G. Effects of bisphenol A on energy balance and accumulation in brown adipose tissue in rats. Chemosphere 2001, 42:917-922.
26. Okuda K., Takiguchi M., Yoshihara S. In vivo estrogenic potential of 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, an active metabolite of bisphenol A, in uterus of ovariectomized rat. Toxicol. Lett. 2010, 197:7-11.
27. Pang Y., Ge W. Epidermal growth factor and TGFα promote zebrafish oocyte maturation in vitro: potential role of the ovarian activin regulatory system. Endocrinology 2002, 143:47-54.
28. Pang Y., Ge W. Gonadotropin regulation of activin βA and activin type IIA receptor expression in the ovarian follicle cells of the zebrafish, Danio rerio. Mol. Cell. Endocrinol. 2002, 188:195-205.
29. Paul-Prasanth B., Shibata Y., Horiguchi R., Nagahama Y. Exposure to diethylstilbestrol during embryonic and larval stages of medaka fish (Oryzias latipes) leads to sex reversal in genetic males and reduced gonad weight in genetic females. Endocrinology 2011, 152:707-717.
30. Petrovic M., Eljarrat E., Lopez De Alda M.J., Barcelo D. Endocrine disrupting compounds and other emerging contaminants in the environment: a survey on new monitoring strategies and occurrence data. Anal. Bioanal. Chem. 2004, 378:549-562.
31. Shen O., Du G., Sun H., Wu W., Jiang Y., Song L., Wang X. Comparison of in vitro hormone activities of selected phthalates using reporter gene assays. Toxicol. Lett. 2009, 191:9-14.
32. Smeets J.M., Rankouhi T.R., Nichols K.M., Komen H., Kaminski N.E., Giesy J.P., van den Berg M. In vitro vitellogenin production by carp (Cyprinus carpio) hepatocytes as a screening method for determining (anti)estrogenic activity of xenobiotics. Toxicol. Appl. Pharmacol. 1999, 157:68-76.
33. Uchida M., Nakamura H., Kagami Y., Kusano T., Arizono K. Estrogenic effects of o,p'-DDT exposure in Japanese medaka (Oryzias latipes). J. Toxicol. Sci. 2010, 35:605-608.
34. Urbatzka R., Rocha E., Reis B., Cruzeiro C., Monteiro R.A., Rocha M.J. Effects of ethinylestradiol and of an environmentally relevant mixture of xenoestrogens on steroidogenic gene expression and specific transcription factors in zebrafish. Environ. Pollut. 2012, 164:28-35.
35. Van den Belt K., Berckmans P., Vangenechten C., Verheyen R., Witters H. Comparative study on the in vitro/in vivo estrogenic potencies of 17β-estradiol, estrone, 17α-ethynylestradiol and nonylphenol. Aquat. Toxicol. 2004, 66:183-195.
36. Woodruff T.J. Bridging epidemiology and model organisms to increase understanding of endocrine disrupting chemicals and human health effects. J. Steroid Biochem. Mol. Biol. 2011, 127:108-117.